PF4 Monoclonal Antibody
Sizes: 50µl, 100µl
Catalogue Numbers: MB12189-50, MB12189-100
Product: 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% BSA
Swiss-Prot: P02776
Host: Rabbit
Reactivity: Human, Rat
Applications: WB, IHC-P, IP,
All Applications: WB: 1/500-1/1000 IHC: 1/50-1/100 IP: 1/20
Background: Released during platelet aggregation. Neutralizes the anticoagulant effect of heparin because it binds more strongly to heparin than to the chondroitin-4-sulfate chains of the carrier molecule. Chemotactic for neutrophils and monocytes. Inhibits endothelial cell proliferation, the short form is a more potent inhibitor than the longer form.
Purification and Purity: Affinity Purified
Storage and Stability: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity: IgG
Bioworld Molecular Weight: Calculated MW: 11 kDa; Observed MW: 11 kDa
Note: For research use only, not for use in diagnostic procedure.
Extra Notes: Western blot analysis of PF4 in rat spleen lysates using PF4 antibody., Western blot analysis of PF4 in A549, HL-60 lysates using PF4 antibody., Immunohistochemistry analysis of paraffin-embedded liver cancer using PF4 antibody. High-pressure and temperature Sodium Citrate pH 6.0 was used for antigen retrieval.
Alternative Name: C-X-C motif chemokine 4; CXCL4; Iroplact; OncostatinA; PF4; Platelet factor 4; SCYB4; short form; Small inducible cytokine subfamily member 4
Immunogen: A synthetic peptide of human PF4
Conjugate: Unconjugated
Modification: Unmodified